Brexpiprazole (Rexulti) for schizophrenia and depression.
D000818:Animals; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D015363:Quinolones / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D018490:Serotonin Agents / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*
D018491:Dopamine Agonists; D015363:Quinolones; D018490:Serotonin Agents; D013876:Thiophenes; C000591922:brexpiprazole